Back to search

Article

In Silico Design of a Multimodal Trimeric Peptide Candidate Predicted to Simultaneously Target Glycemic Control, Autoimmunity, and Pancreatic β-Cell Regeneration in Type 1 Diabetes

2026-02-25

Abstract excerpt

<title>Abstract</title> <p> <bold>Introduction:</bold> Type 1 diabetes mellitus (T1DM) currently affects 9.5 million individuals worldwide, with incidence rising through 2040. Clinical management remains anchored to exogenous insulin replacement, which neither arrests autoreactive CD8⁺ T-cell–mediated insulitis, nor blocks IL-1β–driven β-cell apoptosis, nor restores PDX-1/NGN3-dependent endocrine identity. No a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5812e3ee-833b-5bb8-8e81-8955f4f9a5f9
DOI
10.21203/rs.3.rs-8951973/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
In Silico Design of a Multimodal Trimeric Peptide Candidate Predicted to Simultaneously Target Glycemic Control, Autoimmunity, and Pancreatic β-Cell Regeneration in Type 1 DiabetesDOI 10.21203/rs.3.rs-8951973/v1
Select a neighboring publication to make it the new centre.